FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37765411000001103: Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1711151000001110 Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1711161000001113 Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Has AMP Rizmoic 200microgram tablets (Shionogi BV) true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Is a Naldemedine 200microgram tablets 28 tablet true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naldemedine true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Has specific active ingredient Naldemedine tosylate true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start